Intuitive Biosciences, Inc.

MADISON, WI · Founded 2012 · Medtech · Private

Blood-based lateral flow diagnostic assays that differentiate HIV infection from vaccine-induced seropositivity

Claim this profile

Follows are private to you and power your alerts

Updated · intuitivebio.com

Sector
Medtech
Headquarters
MADISON, WI
Founded
2012
Latest Form D
$1.2M, Oct 2019
Total capital
$4.2M
Federal grants
$606K
2 awards
Rank in peer group#30 of 95
Private capital raised
$3.6M
4 Form D · last Oct 2019
85 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
9 pending · first 2016
Rank in peer group#6 of 95

Capital timeline

2013201420152016201720182019FEDERAL ↑EQUITY ↓Cumulative $3.6M1st Form D$573K3rd Form D$1.3M4th Form D$1.2M
2013201520172019FEDERAL ↑EQUITY ↓Cumulative $3.6M3rd Form D$1.3M4th Form D$1.2M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$1.2M
  • Private capital raisedForm D · SEC · 3rd filing$1.3M
  • Private capital raisedForm D · SEC · 2nd filing$487K
  • Private capital raisedForm D · SEC · 1st filing$573K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

2 records have no date or no amount, so they aren’t placed on the timeline.

Standing among 95 peers

Line = median

Medtech · Instrument

  • Federal grants#30 · top 32%
  • Granted patents#6 · top 6%
  • Linked publications#4 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Craig R. SmithDirectorNamed in SEC Form D filings
  • Harald E NordalDirectorNamed in SEC Form D filings
  • Jason R SmithDirectorNamed in SEC Form D filings
  • Jay R SekelskyDirectorNamed in SEC Form D filings
  • Johan D MichelsenDirectorNamed in SEC Form D filings
  • Shawn D GuseExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 12
Show all 12 patent records

Recent research by its founders

  • Larger Acute Phase Reactions Are Associated with Immunogenicity of an Adjuvanted Recombinant Receptor Binding Domain Protein Vaccine Against SARS-CoV-2 in Rhesus Monkeys20260 cites
  • Using common features of viruses and EVs for a novel EV-based lateral flow test for HIV20250 cites
  • Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys20241 cites
  • MitralPint Inc.Similar federal contract value in Medtech · null in contracts
  • Telo Genomics Corp.Similar federal contract value in Medtech · null in contracts
  • BIACURE THERAPIES, INC.Similar federal contract value in Medtech · null in contracts
  • Precede BiosciencesSimilar federal contract value in Medtech · null in contracts
  • CALVIRI, INC.Similar federal contract value in Medtech · null in contracts
  • IVIEW Therapeutics IncSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .